Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

05/08/2025 01:00

Aug 5 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             6.48                5.55             33.27    
                 (+16.7 pct)         (-4.4 pct)       (+2.6 pct)  
  Operating     loss 340 mln        loss 145 mln          3.55    
                                                      (+18.9 pct) 
  Recurring        515 mln             342 mln            5.93    
                 (+50.8 pct)         (-81.8 pct)      (-8.1 pct)  
  Net              260 mln             122 mln            3.55    
                (+113.1 pct)         (-91.1 pct)      (-27.9 pct) 
  EPS             6.25 yen            2.93 yen         85.27 yen  
  Ann Div                             50.00 yen        50.00 yen  
  -Q2 div                             20.00 yen        20.00 yen  
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T